tradingkey.logo

Celldex Therapeutics Inc

CLDX
View Detailed Chart

22.190USD

+0.210+0.96%
Close 08/01, 16:00ETQuotes delayed by 15 min
1.47BMarket Cap
LossP/E TTM

Celldex Therapeutics Inc

22.190

+0.210+0.96%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.96%

5 Days

-4.97%

1 Month

+0.86%

6 Months

-6.17%

Year to Date

-12.19%

1 Year

-36.20%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 15 analysts
BUY
Current Rating
58.583
Target Price
164.01%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

552
Total
5
Median
6
Average
Company name
Ratings
Analysts
Celldex Therapeutics Inc
CLDX
15
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Exact Sciences Corp
EXAS
27
Ionis Pharmaceuticals Inc
IONS
27
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(5)
Neutral(5)
Buy(3)
Indicators
Sell(2)
Neutral(5)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.321
Neutral
RSI(14)
50.423
Neutral
STOCH(KDJ)(9,3,3)
26.456
Neutral
ATR(14)
1.128
Low Volatility
CCI(14)
-96.483
Neutral
Williams %R
74.900
Sell
TRIX(12,20)
0.271
Sell
StochRSI(14)
24.720
Neutral
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
22.188
Buy
MA10
22.580
Sell
MA20
22.537
Sell
MA50
21.317
Buy
MA100
20.234
Buy
MA200
22.631
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on exploring the science of mast cell biology and the development of transformative therapeutics for patients. Its drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its Barzolvolimab, a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity, which is studied across multiple mast cell driven diseases, including Chronic Urticarias, Prurigo Nodularis and Eosinophilic Esophagitis. The Company’s bispecific antibody platform to support pipeline expansion with additional candidates for inflammatory diseases and oncology. Bispecific Platform includes CDX-585. CDX-585 combines its highly active PD-1 blockade and anti-ILT4 blockade to overcome immunosuppressive signals in T cells and myeloid cells, respectively.
Ticker SymbolCLDX
CompanyCelldex Therapeutics Inc
CEOMr. Anthony S. Marucci
Websitehttps://celldex.com/
KeyAI